EPZM NASDAQ
Epizyme, Inc.
1W: -0.7%
1M: -0.7%
3M: +214.3%
1Y: -73.2%
3Y: -87.5%
5Y: -88.8%
$1.47
Last traded 2022-08-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$289M
-39.0% ▼
5Y CAGR: +2.7%
Total Liabilities
$310M
+7.3% ▲
5Y CAGR: +43.6%
Shareholders Equity
-$21M
-111.2% ▼
Cash & Investments
$177M
-52.7% ▼
5Y CAGR: -6.1%
Total Debt
$239M
+1.4% ▲
5Y CAGR: +218.5%
Net Debt
$141M
+108.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $227M | $87M | $139M | $168M | $98M |
| Short-Term Investments | $50M | $154M | $242M | $205M | $78M |
| Cash & ST Investments | $276M | $240M | $381M | $374M | $177M |
| Net Receivables | $631K | $21M | $4M | $3M | $7M |
| Inventory | $0 | $0 | $0 | $10M | $3M |
| Other Current Assets | $9M | $11M | $15M | $18M | $19M |
| Total Current Assets | $286M | $273M | $399M | $405M | $206M |
| Property, Plant & Equip. | $3M | $2M | $23M | $19M | $22M |
| Goodwill & Intangibles | $0 | $0 | $0 | $47M | $43M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $1M | $909K | $2M | $2M | $19M |
| Total Non-Current Assets | $4M | $3M | $25M | $68M | $83M |
| Total Assets | $289M | $276M | $425M | $474M | $289M |
| — Liabilities — | |||||
| Accounts Payable | $7M | $5M | $9M | $10M | $10M |
| Short-Term Debt | $110K | $16K | $3M | $5M | $4M |
| Deferred Revenue | $29M | $13M | $4M | $0 | $12M |
| Other Current Liabilities | -$11M | $20M | $19M | $29M | $19M |
| Total Current Liabilities | $25M | $38M | $34M | $43M | $45M |
| Long-Term Debt | $0 | $53K | $42M | $231M | $235M |
| Other Non-Current Liab. | $515K | $853K | $13M | $14M | $18M |
| Total Non-Current Liabilities | $29M | $5M | $59M | $245M | $264M |
| Total Liabilities | $54M | $42M | $93M | $289M | $310M |
| — Equity — | |||||
| Common Stock | $7K | $8K | $10K | $10K | $11K |
| Retained Earnings | -$488M | -$587M | -$757M | -$989M | -$1.2B |
| Accumulated OCI | -$49K | -$54K | $19K | $3K | $3K |
| Total Stockholders Equity | $235M | $233M | $331M | $185M | -$21M |
| Total Liabilities & Equity | $289M | $276M | $425M | $474M | $289M |
| — Key Metrics — | |||||
| Total Debt | $110K | $69K | $45M | $236M | $239M |
| Net Debt | -$227M | -$87M | -$94M | $68M | $141M |
| Total Investments | $50M | $154M | $242M | $205M | $78M |